Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member

Arno G. Beer, Christoph Zenzmaier, Michael Schreinlechner, Jenny Haas, Martin F. Dietrich, Joachim Herz, Peter Marschang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Low-density lipoprotein (LDL) receptor-related protein 1B (LRP1B), a member of the LDL receptor family, is frequently inactivated in multiple malignancies including lung cancer. LRP1B is therefore considered as a putative tumor suppressor. Due to its large size (4599 amino acids), until now only minireceptors or receptor fragments have been successfully cloned. To assess the effect of LRP1B on the proliferation of non-small cell lung cancer cells, we constructed and expressed a transfection vector containing the 13.800 bp full-length murine Lrp1b cDNA using a PCR-based cloning strategy. Expression of LRP1B was analyzed by quantitative RT-PCR (qRT-PCR) using primers specific for human LRP1B or mouse Lrp1b. Effective expression of the full length receptor was demonstrated by the appearance of a single 600 kDa band on Western Blots of HEK 293 cells. Overexpression of Lrp1b in non-small cell lung cancer cells with low or absent endogenous LRP1B expression significantly reduced cellular proliferation compared to empty vector-transfected control cells. Conversely, in Calu-1 cells, which express higher endogenous levels of the receptor, siRNA-mediated LRP1B knockdown significantly enhanced cellular proliferation. Taken together, these findings demonstrate that, consistent with the postulated tumor suppressor function, overexpression of full-length Lrp1b leads to impaired cellular proliferation, while LRP1B knockdown has the opposite effect. The recombinant Lrp1b construct represents a valuable tool to unravel the largely unknown physiological role of LRP1B and its potential functions in cancer pathogenesis.

Original languageEnglish (US)
Pages (from-to)68721-68733
Number of pages13
JournalOncotarget
Volume7
Issue number42
DOIs
StatePublished - Oct 18 2016

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-1
LDL Receptors
Non-Small Cell Lung Carcinoma
Growth
Cell Proliferation
Neoplasms
LDL-Receptor Related Proteins
Polymerase Chain Reaction
HEK293 Cells
Small Interfering RNA
Transfection
Organism Cloning
Lung Neoplasms
Complementary DNA
Western Blotting
Amino Acids

Keywords

  • overexpression
  • proliferation
  • siRNA
  • tumor suppressor

ASJC Scopus subject areas

  • Oncology

Cite this

Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member. / Beer, Arno G.; Zenzmaier, Christoph; Schreinlechner, Michael; Haas, Jenny; Dietrich, Martin F.; Herz, Joachim; Marschang, Peter.

In: Oncotarget, Vol. 7, No. 42, 18.10.2016, p. 68721-68733.

Research output: Contribution to journalArticle

Beer, Arno G. ; Zenzmaier, Christoph ; Schreinlechner, Michael ; Haas, Jenny ; Dietrich, Martin F. ; Herz, Joachim ; Marschang, Peter. / Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member. In: Oncotarget. 2016 ; Vol. 7, No. 42. pp. 68721-68733.
@article{0978729b8cd64938b8276b61aeda3eb7,
title = "Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member",
abstract = "Low-density lipoprotein (LDL) receptor-related protein 1B (LRP1B), a member of the LDL receptor family, is frequently inactivated in multiple malignancies including lung cancer. LRP1B is therefore considered as a putative tumor suppressor. Due to its large size (4599 amino acids), until now only minireceptors or receptor fragments have been successfully cloned. To assess the effect of LRP1B on the proliferation of non-small cell lung cancer cells, we constructed and expressed a transfection vector containing the 13.800 bp full-length murine Lrp1b cDNA using a PCR-based cloning strategy. Expression of LRP1B was analyzed by quantitative RT-PCR (qRT-PCR) using primers specific for human LRP1B or mouse Lrp1b. Effective expression of the full length receptor was demonstrated by the appearance of a single 600 kDa band on Western Blots of HEK 293 cells. Overexpression of Lrp1b in non-small cell lung cancer cells with low or absent endogenous LRP1B expression significantly reduced cellular proliferation compared to empty vector-transfected control cells. Conversely, in Calu-1 cells, which express higher endogenous levels of the receptor, siRNA-mediated LRP1B knockdown significantly enhanced cellular proliferation. Taken together, these findings demonstrate that, consistent with the postulated tumor suppressor function, overexpression of full-length Lrp1b leads to impaired cellular proliferation, while LRP1B knockdown has the opposite effect. The recombinant Lrp1b construct represents a valuable tool to unravel the largely unknown physiological role of LRP1B and its potential functions in cancer pathogenesis.",
keywords = "overexpression, proliferation, siRNA, tumor suppressor",
author = "Beer, {Arno G.} and Christoph Zenzmaier and Michael Schreinlechner and Jenny Haas and Dietrich, {Martin F.} and Joachim Herz and Peter Marschang",
year = "2016",
month = "10",
day = "18",
doi = "10.18632/oncotarget.11897",
language = "English (US)",
volume = "7",
pages = "68721--68733",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "42",

}

TY - JOUR

T1 - Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member

AU - Beer, Arno G.

AU - Zenzmaier, Christoph

AU - Schreinlechner, Michael

AU - Haas, Jenny

AU - Dietrich, Martin F.

AU - Herz, Joachim

AU - Marschang, Peter

PY - 2016/10/18

Y1 - 2016/10/18

N2 - Low-density lipoprotein (LDL) receptor-related protein 1B (LRP1B), a member of the LDL receptor family, is frequently inactivated in multiple malignancies including lung cancer. LRP1B is therefore considered as a putative tumor suppressor. Due to its large size (4599 amino acids), until now only minireceptors or receptor fragments have been successfully cloned. To assess the effect of LRP1B on the proliferation of non-small cell lung cancer cells, we constructed and expressed a transfection vector containing the 13.800 bp full-length murine Lrp1b cDNA using a PCR-based cloning strategy. Expression of LRP1B was analyzed by quantitative RT-PCR (qRT-PCR) using primers specific for human LRP1B or mouse Lrp1b. Effective expression of the full length receptor was demonstrated by the appearance of a single 600 kDa band on Western Blots of HEK 293 cells. Overexpression of Lrp1b in non-small cell lung cancer cells with low or absent endogenous LRP1B expression significantly reduced cellular proliferation compared to empty vector-transfected control cells. Conversely, in Calu-1 cells, which express higher endogenous levels of the receptor, siRNA-mediated LRP1B knockdown significantly enhanced cellular proliferation. Taken together, these findings demonstrate that, consistent with the postulated tumor suppressor function, overexpression of full-length Lrp1b leads to impaired cellular proliferation, while LRP1B knockdown has the opposite effect. The recombinant Lrp1b construct represents a valuable tool to unravel the largely unknown physiological role of LRP1B and its potential functions in cancer pathogenesis.

AB - Low-density lipoprotein (LDL) receptor-related protein 1B (LRP1B), a member of the LDL receptor family, is frequently inactivated in multiple malignancies including lung cancer. LRP1B is therefore considered as a putative tumor suppressor. Due to its large size (4599 amino acids), until now only minireceptors or receptor fragments have been successfully cloned. To assess the effect of LRP1B on the proliferation of non-small cell lung cancer cells, we constructed and expressed a transfection vector containing the 13.800 bp full-length murine Lrp1b cDNA using a PCR-based cloning strategy. Expression of LRP1B was analyzed by quantitative RT-PCR (qRT-PCR) using primers specific for human LRP1B or mouse Lrp1b. Effective expression of the full length receptor was demonstrated by the appearance of a single 600 kDa band on Western Blots of HEK 293 cells. Overexpression of Lrp1b in non-small cell lung cancer cells with low or absent endogenous LRP1B expression significantly reduced cellular proliferation compared to empty vector-transfected control cells. Conversely, in Calu-1 cells, which express higher endogenous levels of the receptor, siRNA-mediated LRP1B knockdown significantly enhanced cellular proliferation. Taken together, these findings demonstrate that, consistent with the postulated tumor suppressor function, overexpression of full-length Lrp1b leads to impaired cellular proliferation, while LRP1B knockdown has the opposite effect. The recombinant Lrp1b construct represents a valuable tool to unravel the largely unknown physiological role of LRP1B and its potential functions in cancer pathogenesis.

KW - overexpression

KW - proliferation

KW - siRNA

KW - tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=85020369190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020369190&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.11897

DO - 10.18632/oncotarget.11897

M3 - Article

VL - 7

SP - 68721

EP - 68733

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 42

ER -